D-0147-2021 Class III Terminated

Recalled by SCA Pharmaceuticals — Windsor, CT

FDA drug recall D-0147-2021 was initiated by SCA Pharmaceuticals on Nov 20, 2020 and is designated Class III. Reason for recall: Subpotency: Out-of-specification stability test result for low potency was obtained. The recall status is terminated (terminated Jun 24, 2021). Affected quantity: 4,843 syringes.

Recall details

Product Type
Drugs
Report Date
Dec 23, 2020
Initiation Date
Nov 20, 2020
Termination Date
Jun 24, 2021
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
4,843 syringes

Product description

Fentanyl, 250 mcg/ 5mL, Injection for IV or IM use, Rx only, SCA Pharmaceuticals, 8821 Knoedl Ct., Little Rock, AR 72205

Reason for recall

Subpotency: Out-of-specification stability test result for low potency was obtained.

Distribution pattern

Product was distributed to three hospitals in MO & LA.

Code information

Lot #: 1220021578, Exp 12/2/2020; 1220021732, Exp 12/9/2020; 1220022385, Exp 12/29/2020; 1220022582, Exp 1/6/2021

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0147-2021
openFDA file date
Nov 10, 2026
Loaded by RegDataLab
Nov 11, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-0147-2021. Report a data issue: hello@regdatalab.com.